Literature DB >> 25728025

Antioxidant activity and inhibition of α-glucosidase by hydroxyl-functionalized 2-arylbenzo[b]furans.

Jung-Feng Hsieh1, Wei-Jen Lin2, Kai-Fa Huang3, Jiahn-Haur Liao3, Ming-Jaw Don2, Chien-Chang Shen2, Young-Ji Shiao2, Wen-Tai Li4.   

Abstract

This study synthesized a series of hydroxyl-functionalized 2-arylbenzo[b]furans based on the structure of tournefolic acid A and evaluated them for antioxidant and α-glucosidase inhibitory activities. Compounds 5a, 5e, and 5n showed remarkable inhibition of α-glucosidase (IC50 values of 1.9-3.0 μM), and they appear to be even more potent than quercetin. A kinetic binding study indicated that compounds 5a and 5n used a mechanism of mixed-competition to inhibit α-glucosidase. This study also revealed that compounds 5a and 5n bind to either the α-glucosidase or α-glucosidase-4-NPGP complex. Using the crystal structure of the Saccharomyces cerevisiae α-glucosidase, the molecular docking study has predicted the binding of compounds 5a and 5n to the active site of α-glucosidase through both hydrophobic and hydrogen interactions. A DPPH radical scavenging assay further showed that most hydroxyl-functionalized 2-arylbenzo[b]furans possess antioxidant activity. The exception was compound 5p, which has only one hydroxyl group on the 2-phenyl ring of 2-arylbenzo[b]furan. Our results indicate that hydroxyl-functionalized 2-arylbenzo[b]furans possess both antidiabetic as well as antioxidant properties.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alpha-glucosidase; Antioxidant; DPPH radical scavenging assay; Hydroxyl-functionalized 2-arylbenzo[b]furans

Mesh:

Substances:

Year:  2015        PMID: 25728025     DOI: 10.1016/j.ejmech.2015.02.024

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Exploring the interaction between Salvia miltiorrhiza and α-glucosidase: insights from computational analysis and experimental studies.

Authors:  Hongjin Tang; Dongsheng Zhao; Zhenglian Xue
Journal:  RSC Adv       Date:  2018-07-09       Impact factor: 4.036

2.  Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.

Authors:  Amit Kumar; Francesca Pintus; Amalia Di Petrillo; Rosaria Medda; Paola Caria; Maria João Matos; Dolores Viña; Enrico Pieroni; Francesco Delogu; Benedetta Era; Giovanna L Delogu; Antonella Fais
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

3.  Synthesis, In Vitro Evaluation and Molecular Docking of the 5-Acetyl-2-aryl-6-hydroxybenzo[b]furans against Multiple Targets Linked to Type 2 Diabetes.

Authors:  Malose J Mphahlele; Yee Siew Choong; Marole M Maluleka; Samantha Gildenhuys
Journal:  Biomolecules       Date:  2020-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.